Media
ProAxsis Coverage and Interviews
Company of the Month – Providing the Evidence Needed to Evaluate New Medicines
ProAxsis is a commercial protease biomarker-led research company supporting drug development...
ProAxsis Evaluates Point-of-Use Test for COPD Exacerbations
The 21-month clinical research study with Imperial College London will assess...
ProAxsis eyes COPD market breakthrough with Imperial College London study
https://www.youtube.com/watch?v=um2GXk6IHTQ EMV Capital (AIM:EMVC, FRA:NTK1) CEO Dr Ilian Iliev and ProAxsis managing...
ProAxsis Transitions to Independent Growth Company to Advance Respiratory Research
A new fundraise will support commercial scale-up and the development of...
NI university spin-out plans £1m raise to support respiratory drug development
NI university spin-out plans £1m raise to support respiratory drug development...